Molbio Diagnostics
add_icon

Molbio Diagnostics

1,263.80
+45.00
(3.69%)
Market Cap
14,564.03 Cr
PE Ratio
85.63
Volume
15,79,734.00
Day High - Low
1,283.50 - 1,227.60
52W High-Low
1,686.80 - 807.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
14,564.03 Cr
EPS
14.77
PE Ratio
85.63
PB Ratio
10.26
Book Value
118.84
EBITDA
330.90
Dividend Yield
0.00 %
Industry
-
Sector
-
Return on Equity
12.54
Debt to Equity
0.28
Forecast For
Actual

Company News

View All News
Caret
neutral
Molbio Diagnostics Limited will host a virtual group meeting with investors and analysts on September 22, 2026, at 11:00 am IST. The discussion will cover general business outlook without disclosing unpublished price-sensitive information.
positive
Molbio Diagnostics reported Q1FY27 consolidated net profit of ₹527.44 million, a sharp recovery from the ₹239.44 million loss in Q1FY26. Revenue rose 309% to ₹4,083.76 million. The company also completed its IPO in August 2026.
neutral
Molbio Diagnostics Limited has scheduled an earnings conference call for September 8, 2026, at 4:00 pm IST. The session will discuss financial performance for the quarter ended June 30, 2026.

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
41.57 %
Net Income Growth
18.40 %
Cash Flow Change
-82.45 %
ROE
-12.49 %
ROCE
-20.01 %
EBITDA Margin (Avg.)
-13.34 %

Quarterly Financial Results

Quarterly Financials
Jun 2025
Mar 2026
Jun 2026
Revenue
101
565
412
Expenses
116
402
308
EBITDA
-15
164
104
Operating Profit %
-16 %
28 %
25 %
Depreciation
12
20
17
Interest
4
12
11
Profit Before Tax
-31
132
76
Tax
-7
36
23
Net Profit
-24
96
53
EPS in ₹
-2.10
8.05
5.21

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
315
845
940
1,034
1,221
1,462
2,148
Fixed Assets
100
115
252
286
289
290
536
Current Assets
129
556
634
611
823
930
1,385
Capital Work in Progress
31
112
11
5
2
27
11
Investments
0
0
0
6
6
46
6
Other Assets
184
618
677
737
924
1,099
1,595
Total Equity & Liabilities
315
845
940
1,034
1,221
1,462
2,148
Current Liabilities
206
336
212
258
343
442
557
Non Current Liabilities
234
175
16
39
50
53
282
Total Equity
-125
335
711
737
829
967
1,309
Reserve & Surplus
-127
333
708
719
821
966
1,158
Share Capital
2
2
2
2
2
2
11

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
2026
Net Cash Flow
11
-9
43
-67
138
273
Investing Activities
-145
-88
-40
-45
-123
-54
Operating Activities
360
101
64
10
287
50
Financing Activities
-204
-22
18
-32
-26
276

Share Holding

% Holding
Aug 2025
Aug 2026
Promoter
46.65 %
41.29 %
FIIs
0.00 %
1.51 %
DIIs
0.00 %
16.37 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
27.64 %
Others
53.35 %
13.19 %
No of Share Holders
39
42

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
05 Sept 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Sept 2026 1,086.30 1,160.50

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HDFC Innovation Fund Direct-Growth
0.37%
108414
0.37%
0.37%
WhiteOak Capital Aggressive Hybrid Fund Direct-Growth
0.90%
45177
0.90%
0.90%
Kotak Large Cap Fund Direct-Growth
0.30%
0
0.00%
0.30%
Edelweiss Recently Listed IPO Fund Direct-Growth
0.59%
0
0.00%
0.59%
HDFC Pharma And Healthcare Fund Direct-Growth
1.77%
0
0.00%
1.77%
HDFC Value Fund Direct Plan-Growth
0.44%
0
0.00%
0.44%
ICICI Prudential Exports and Services Fund Direct-Growth
1.04%
0
0.00%
1.04%
Kotak Aggressive Hybrid Fund Direct-Growth
1.40%
0
0.00%
1.40%
Kotak Conservative Hybrid Fund Direct-Growth
0.17%
0
0.00%
0.17%
Kotak Consumption Fund Direct-Growth
0.91%
0
0.00%
0.91%
Kotak Contra Fund Direct-Growth
1.02%
0
0.00%
1.02%
Kotak Healthcare Fund Direct-Growth
4.53%
0
0.00%
4.53%
Edelweiss Equity Savings Fund Direct-Growth
0.61%
0
0.00%
0.61%
Kotak Multi Asset Allocation Fund Direct-Growth
0.03%
0
0.00%
0.03%
HDFC MNC Fund Direct-Growth
1.51%
0
0.00%
1.51%
Mirae Asset Small Cap Fund Direct-Growth
0.30%
0
0.00%
0.30%
Mirae Asset Flexi Cap Fund Direct-Growth
1.02%
0
0.00%
1.02%
Motilal Oswal Large Cap Fund Direct-Growth
0.43%
0
0.00%
0.43%
Nippon India Innovation Fund Direct-Growth
0.60%
0
0.00%
0.60%
Nippon India Pharma Fund Direct-Growth
0.44%
0
0.00%
0.44%
PGIM India Large and Mid Cap Fund Direct-Growth
0.81%
0
0.00%
0.81%
PGIM India Retirement Fund Direct-Growth
0.94%
0
0.00%
0.94%
Tata India Pharma & Healthcare Fund Direct-Growth
0.87%
0
0.00%
0.87%
Mirae Asset Healthcare Fund Direct-Growth
1.44%
0
0.00%
1.44%
WhiteOak Capital Balanced Advantage Fund Direct-Growth
0.01%
0
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
52.71
ATR(14)
Less Volatile
118.64
STOCH(9,6)
Neutral
38.15
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Uptrend But Slowing Down
10.02
WillR(14)
Neutral
-71.82